ERCC2 Antibody

1. Polymorphic variants of XRCC1 Arg399Gln and XPD Lys751Gln are not associated with the risk of gastric cancer in the Kashmiri population. PMID: 30225185
2. A significant association was discovered between the rs1799793 A allele and increased Diffuse Large B-Cell Lymphoma risk (P=0.031, OR=1.928, 95% CI=1.052-3.534). The C allele of rs13181 was obviously associated with elevated Diffuse Large B-Cell Lymphoma susceptibility (P=0.047, OR=1.820, 95% CI=1.002-3.305). PMID: 30279407
3. Results identified a significant relationship between SNP rs13181 of ERCC2 and an increased risk of endometrial cancer development. PMID: 30194171
4. ERCC2 polymorphism is associated with breast cancer susceptibility. PMID: 29544444
5. These results provide new evidence to reveal the role of XPD in Cutaneous squamous cell carcinoma A431 cells. PMID: 29362353
6. studied SNPs in XRCC1 and XPD have no association with the incidence of age related cataract in the analyzed group of subjects. PMID: 28560653
7. results indicate that the ERCC2 Lys751Gln polymorphism might be important in stimulating the development of pancreatic cancer, especially for Asians. PMID: 28223548
8. our results suggested that ERCC2 Asp312Asn polymorphism is associated with increased cancer risk. A significantly increased cancer risk was observed in Asian populations, but not in Caucasian populations. PMID: 28489582
9. hospital workers as a category are at risk for genotoxic damage caused by chronic exposure to xenobiotics. The higher levels of cytogenetic damage observed among GSTT1 null, XPD 751 and XPC 939 CC homozygote subjects confirm the importance of the genetic polymorphisms analysis associated to genotoxicological studies. PMID: 28434254
10. XPD Lys/Lys might play a facilitating role in the development of OCD. PMID: 29264886
11. XPG rs2296147T>C polymorphism is associated with response to therapy in cancer. PMID: 27588464
12. We found that the T allele of ERCC2-rs1799793 and the A allele of ERCC3-rs4150441, interaction between rs1799793 and rs4150441, and haplotype containing the rs1799793T and rs11615-T alleles were all associated with increased osteosarcoma risk PMID: 28474168
13. meta-analysis indicates that XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms may not be associated with the risk of ovarian cancer PMID: 27863412
14. Results show that the response to treatment depended of the variability in genes engaged in drugs' transport ABCC2 c.-24C>T and ABCB1 p.Ser893Ala/Thr and in DNA repair machinery ERCC2 p.Lys751Gln. PMID: 27527855
15. Results indicate that ERCC excision repair 2 (ERCC2) is a potential target of miR-770-5p. PMID: 27449101
16. The allele combination of CGC from hOGG1, ITGA2 and XPD polymorphisms was significantly associated with increased odds of nasopharyngeal carcinoma. PMID: 29121049
17. CHD1 facilitates substrate handover from XPC to the downstream TFIIH (transcription factor IIH). PMID: 29018037
18. our study provided preliminary evidence that the ERCC2 rs50872 T allele was associated with a favorable survival while the XRCC1 rs25487 A allele was associated with a worse survival outcome for advanced NSCLC patients. PMID: 27465648
19. Genetic polymorphism in ERCC2 gene is associated with response to chemotherapy in osteosarcoma. PMID: 28388903
20. XPD 312 single nucleotide polymorphism is associated with Non-Small-Cell Lung Cancer. PMID: 27908619
21. At 24 months of follow-up, patients with xeroderma pigmentosum group D protein (XPD) c.934AA genotype presented lower progression-free survival and overall survival in Kaplan-Meier estimates. PMID: 26918827
22. the association of six non-synonymous coding variants from XRCC1, XRCC3 and XPD genes with hepatocellular carcinoma risk, was assessed. PMID: 27306318
23. characterized by a broad spectrum of base changes. In addition, we note an association between the activity of this signature and smoking that is independent of ERCC2 mutation status, providing genomic evidence of tobacco-related mutagenesis in urothelial cancer PMID: 27111033
24. Hypermethylation within the promoter region of the ERCC2 gene is associated with gastric cancer. PMID: 27607585
25. significant interactions between ERCC2 (Lys751Gln) and ERCC3 (7122 A>G) genotypes polymorphism and cadmium exposure in association with nasal polyposis disease PMID: 27838878
26. ERCC2 mutation is associated with sarcoma. PMID: 27498913
27. The carriage of homozygous minor allele of DNA repair gene XPD Gln751Gln is a risk factor for thyroid cancer in persons from Ukrainian population exposed to ionizing radiation and is associated with the increased levels of chromosomal instability. PMID: 28230823
28. In conclusion, we provide a useful resource on the mutational landscape of ERCC2 mutations in hereditary BC/OC patients and, as our key finding, we demonstrate the complexity of correct interpretation for the discovery of "bonafide" breast cancer susceptibility genes PMID: 27504877
29. Accumulating evidence suggests that XPA and the helicase activity of transcription factor IIH (TFIIH) cooperate to verify abnormalities in damaged DNA chemistry. (Review) PMID: 27264556
30. The data indicate that XPD, as a part of the TFIIH complex, due to its iron-sulfur center interacts with the iron sulfur cluster assembly proteins and may interact with other proteins in the cell to mediate a diverse set of biological functions including cell cycle regulation, mitosis, and mitochondrial function. (Review) PMID: 27262611
31. genetic association studies in population of women in Poland: Data suggest that an SNP in ERCC2 (C to A, R156R, rs238406) is associated with ovarian carcinoma; this SNP is also associated with ovarian cancer progression, assessed by the degree of histological grades and FIGO staging. PMID: 27888704
32. The analysis results showed that the following polymorphisms were correlated with susceptibility to lung cancer: rs4646903 in CYP1A1 (P < 0.001), rs1048943 in CYP1A1 (P < 0.001), rs1695 in GSTP1 (P < 0.05), rs13181 in ERCC2 (P < 0.001), and rs25487 in XRCC1 (P < 0.05); no such correlation existed in rs861539 in XRCC3 (P > 0.05). PMID: 27819744
33. There was no association between the XPD Lys751Gln polymorphism and CRC risk. PMID: 27686263
34. Polymorphisms in XPD gene is associated with gastrointestinal stromal tumours. PMID: 27460091
35. No association was found between ERCC2 rs13181, and ERCC2 rs1799793 and overall survival of gastric cancer. PMID: 27173253
36. Study provides evidence that genetic polymorphisms in XPD-751, XRCC1-194 and XRCC1-399 were all correlated with non-small cell lung cancer occurrence. PMID: 25308691
37. the ERCC2 rs13181 polymorphism is correlated with an increased risk of gliomas in codominant and recessive models, which suggests that this polymorphism could influence the etiology of gliomas. PMID: 27323065
38. XPD gene polymorphism is associated with acute myeloid leukemia. PMID: 26779634
39. we conclude that ERCC2 gene polymorphism R156R may be associated with an increased risk of endometrial cancer. PMID: 26349749
40. No significant association was found for XPD Asp312Asn polymorphism with the risk of autism spectrum disorder. PMID: 27064873
41. Frequency of XPD-Gln in IFH suggests that this variant may protect against OSCC. PMID: 26742000
42. Data did not find any association between ERCC2 or ERCC3 gene polymorphisms and the development of osteosarcoma. PMID: 27051024
43. Photosensitive form of trichothiodystrophy associated with a novel mutation in the XPD gene. PMID: 26577220
44. No significant association was found between the ERCC2 rs13181 polymorphism and the risk of pancreatic cancer in the codominant, dominant, and recessive models. PMID: 27051038
45. XPD Lys751Gln polymorphism may be a risk factor for CCRCC. Regarding the XRCC3 Thr241Met polymorphism, an association with CCRCC was found only in XRCC3 Thr241Met/XPD Lys751Gln combined genotypes. PMID: 26682510
46. Results found no significant association between ERCC2 rs13181 polymorphism and breast cancer in Chinese population. PMID: 26985954
47. Polymorphisms of ERCC2 gene are associated with HPV-positive cervical cancer. PMID: 25812040
48. Our data suggest that deregulation of ERCC2 in head and neck cancer (HNC) has the potential to predict a more aggressive cancer phenotype and may be considered a possible biomarker for improved diagnosis and prognosis of HNC. PMID: 26659720
49. The aim of this study was to investigate the association between polymorphisms of XRCC1 Arg399Gln, XRCC3 Thr241Met, and XPD Lys751Gln and laryngeal cancer risk. PMID: 26898429
50. ERCC1 rs11615 and rs3212986 and ERCC2 rs13181 and rs1799793 polymorphisms were genotyped using the polymerase chain reaction restriction fragment length polymorphism PMID: 26823845

Show More

Hide All

HGNC: 3434

OMIM: 126340

KEGG: hsa:2068

STRING: 9606.ENSP00000375809

UniGene: Hs.487294